News from stempeutics research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

30 May, 2016, 10:30 BST DCGI Gives Limited Approval to Market FIRST Allogeneic Cell Therapy Product in India Stempeutics puts India on the 'World map of Regenerative Medicine'

- DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due to Buerger's disease - Stempeucel® becomes 5th...


30 May, 2016, 02:30 BST DCGI Gives Limited Approval to Market FIRST Allogeneic Cell Therapy Product in India Stempeutics puts India on the 'World map of Regenerative Medicine'

- DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due to Buerger's disease - Stempeucel® becomes 5th...


10 Mar, 2016, 11:56 GMT Make in India - Human Resources for the Global Stage

There is an unprecedented focus around human resources, talent engagement, leadership, and related best practices in the recent time. Is it time to...


08 Jun, 2015, 09:00 BST Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel®'

- The First Company in the World to be Granted a Japanese Process Patent for a Stem Cell Drug Based on Pooling Technology - A New Treatment Which...


08 Jun, 2015, 09:00 BST Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel®'

- The First Company in the World to be Granted a Japanese Process Patent for a Stem Cell Drug Based on Pooling Technology - A New Treatment Which...


27 Apr, 2015, 09:00 BST Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel'

- The First Company in the World to be Granted a Process Patent by the State Intellectual Property Office of China (SIPO) For a Stem Cell Drug Based...


27 Apr, 2015, 02:00 BST Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel'

- The First Company in the World to be Granted a Process Patent by the State Intellectual Property Office of China (SIPO) For a Stem Cell Drug Based...


23 Mar, 2015, 06:30 GMT Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency (EMA) for its Novel Stem Cell Drug 'Stempeucel®'

- The First Stem Cell Drug Based on Pooling Technology to be Granted ATMP Classification - A New Treatment Which Offers Hope to Patients Suffering...